Zinox Tablet contains Garenoxacin 200 mg, a potent fluoroquinolone antibiotic indicated for the treatment of various bacterial infections. Garenoxacin exhibits broad-spectrum activity against both Gram-positive and Gram-negative pathogens by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. Zinox is primarily prescribed for respiratory tract infections, including community-acquired pneumonia, acute exacerbations of chronic bronchitis, and sinusitis, as well as urinary tract infections and skin and soft tissue infections caused by susceptible organisms. The tablet is administered orally, with dosage and duration tailored according to the severity and type of infection, patient age, renal function, and clinical response. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, as well as potential central nervous system effects like dizziness or headache. Caution is advised in patients with a history of hypersensitivity to fluoroquinolones, those with tendon disorders, or underlying neurological conditions. Zinox should be used under medical supervision, ensuring appropriate microbiological diagnosis and susceptibility testing to minimize the risk of resistance development. Patients are advised to complete the full prescribed course to achieve optimal therapeutic outcomes and reduce the likelihood of recurrent infection.